| Q30945792 | 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. |
| Q37363776 | 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease |
| Q92996027 | 3D quantitative synthetic MRI-derived cortical thickness and subcortical brain volumes: Scan-rescan repeatability and comparison with conventional T1 -weighted images |
| Q56989534 | A Graph-Based Integration of Multimodal Brain Imaging Data for the Detection of Early Mild Cognitive Impairment (E-MCI) |
| Q30772153 | A critical discussion of the role of neuroimaging in mild cognitive impairment |
| Q30835966 | A data-driven model of biomarker changes in sporadic Alzheimer's disease |
| Q37446899 | A hypnic hypothesis of Alzheimer's disease. |
| Q36891020 | A longitudinal investigation of the relationship between crowding and reading: A neurodegenerative approach |
| Q31147684 | A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease |
| Q64080813 | A study on changes of the resting-state brain function network in patients with amnestic mild cognitive impairment |
| Q60546742 | ALTEA: A Software Tool for the Evaluation of New Biomarkers for Alzheimer's Disease by Means of Textures Analysis on Magnetic Resonance Images |
| Q35597131 | Aberrant default mode network in subjects with amnestic mild cognitive impairment using resting-state functional MRI. |
| Q43241965 | Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease |
| Q98947788 | Abundance of P-glycoprotein and other drug transporters at the human blood-brain barrier in Alzheimer's Disease: a quantitative targeted proteomic study |
| Q30461288 | Accent processing in dementia |
| Q36088150 | Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry |
| Q37064559 | Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment |
| Q35857470 | Advances in the early detection of Alzheimer's disease |
| Q48856161 | Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study |
| Q33406823 | Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment |
| Q37228160 | Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition |
| Q40107949 | Alzheimer's disease or Alzheimer's syndrome?: a longitudinal computed tomography neuroradiological follow-up study of 56 cases diagnosed clinically as Alzheimer's disease |
| Q37203031 | Alzheimer's disease risk gene, GAB2, is associated with regional brain volume differences in 755 young healthy twins |
| Q35859464 | Alzheimer's pathology in primary progressive aphasia |
| Q35152147 | Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss |
| Q35053524 | Amyloid-β associated cortical thinning in clinically normal elderly |
| Q48830480 | Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies? |
| Q48441003 | An enhanced voxel-based morphometry method to investigate structural changes: application to Alzheimer's disease |
| Q46031539 | Anterior thalamic lesions stop synaptic plasticity in retrosplenial cortex slices: expanding the pathology of diencephalic amnesia. |
| Q38076765 | Aripiprazole in the treatment of Alzheimer's disease |
| Q97883015 | Assessment of Alzheimer's Disease Based on Texture Analysis of the Entorhinal Cortex |
| Q38067323 | Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease |
| Q35749784 | Atrophy rates of entorhinal cortex in AD and normal aging |
| Q22242926 | Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease |
| Q33727158 | Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease |
| Q34584137 | Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging |
| Q33518172 | Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data |
| Q39809906 | Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis |
| Q37769104 | Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives |
| Q22252362 | Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease |
| Q26996299 | Brain imaging in Alzheimer disease |
| Q24658560 | Brain mapping as a tool to study neurodegeneration |
| Q49028345 | Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers |
| Q33776799 | Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease |
| Q36722181 | Cascading network failure across the Alzheimer's disease spectrum |
| Q40881715 | Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease. |
| Q49787280 | Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer's Disease: A Multiparametric Neuroimaging Study |
| Q39432592 | Cerebrospinal Fluid Biomarkers in Alzheimer's Disease-From Brain Starch to Bench and Bedside |
| Q92584243 | Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study |
| Q37230895 | Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice |
| Q37130148 | Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme |
| Q48706392 | Classification and localization of early-stage Alzheimer's disease in magnetic resonance images using a patch-based classifier ensemble |
| Q42335495 | Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease |
| Q39983468 | Clinical application of measurement of hippocampal atrophy in degenerative dementias |
| Q44791946 | Cognitive impairment: classification by 1H magnetic resonance spectroscopy. |
| Q48182616 | Cognitive rehabilitation changes memory-related brain activity in people with Alzheimer disease. |
| Q55422114 | Combining Cognitive, Genetic, and Structural Neuroimaging Markers to Identify Individuals with Increased Dementia Risk. |
| Q93106620 | Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum |
| Q37730015 | Correlating familial Alzheimer's disease gene mutations with clinical phenotype |
| Q36785225 | Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers |
| Q29619733 | Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease |
| Q48164562 | Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study |
| Q51011342 | Damage to the cingulum contributes to Alzheimer's disease pathophysiology by deafferentation mechanism. |
| Q52381991 | Data-driven models of dominantly-inherited Alzheimer's disease progression. |
| Q48163692 | Decreases in Phospholipids Containing Adrenic and Arachidonic Acids Occur in the Human Hippocampus over the Adult Lifespan |
| Q38965765 | Delirium and mental health history as predictors of aggression in individuals with dementia in inpatient settings. |
| Q38653373 | Dementia risk and prevention by targeting modifiable vascular risk factors. |
| Q48960851 | Different Scales of Cortical Organization are Selectively Targeted in the Progression to Alzheimer's Disease |
| Q98165182 | Disconnection of the right superior parietal lobule from the precuneus is associated with memory impairment in oldest-old Alzheimer's disease patients |
| Q37126328 | Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease |
| Q37011873 | Disrupted white matter integrity is associated with cognitive deficits in patients with amnestic mild cognitive impairment: An atlas-based study |
| Q30492809 | Disruption of functional connectivity in clinically normal older adults harboring amyloid burden |
| Q91637546 | Distinct Brain Regions in Physiological and Pathological Brain Aging |
| Q36744396 | Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration |
| Q34134801 | Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations |
| Q42441456 | Distractibility during selection-for-action: differential deficits in Huntington's disease and following frontal lobe damage |
| Q48957599 | Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study |
| Q48287323 | Does registration of serial MRI improve diagnosis of dementia? |
| Q35663562 | Dynamic Bayesian network modeling for longitudinal brain morphometry |
| Q46191030 | Dynamics of gray matter loss in Alzheimer's disease. |
| Q38379843 | ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation |
| Q30770505 | Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging |
| Q48719968 | Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study |
| Q37115603 | Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults |
| Q37220884 | Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging |
| Q34196338 | Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimer's disease |
| Q51567260 | Electrical detection of beta-amyloid (1-40) using scanning tunneling microscopy. |
| Q48219660 | Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. |
| Q35135873 | Event-related potential markers of brain changes in preclinical familial Alzheimer disease |
| Q47683018 | Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. |
| Q33624213 | Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. |
| Q92823598 | FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease |
| Q49077318 | Feature extraction and strategy of analyzing structural neuroimaging in dementia |
| Q33917390 | Feature selective temporal prediction of Alzheimer's disease progression using hippocampus surface morphometry. |
| Q51935726 | Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. |
| Q30410741 | Functional neuroanatomy of auditory scene analysis in Alzheimer's disease |
| Q27307709 | Functional neuroanatomy of spatial sound processing in Alzheimer's disease. |
| Q48513934 | Functional-anatomic correlates of memory retrieval that suggest nontraditional processing roles for multiple distinct regions within posterior parietal cortex. |
| Q37170650 | Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations |
| Q28596011 | Genetic variants in Alzheimer disease - molecular and brain network approaches |
| Q34984519 | High "normal" blood glucose is associated with decreased brain volume and cognitive performance in the 60s: the PATH through life study |
| Q33652639 | Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. |
| Q48162338 | Hydrocephalus compacted cortex and hippocampus and altered their output neurons in association with spatial learning and memory deficits in rats. |
| Q40518545 | Imaging cerebral atrophy: normal ageing to Alzheimer's disease |
| Q30491715 | Imaging plus X: multimodal models of neurodegenerative disease. |
| Q34046428 | Imaging the progression of Alzheimer pathology through the brain |
| Q48719933 | In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease |
| Q35691484 | Inclusion of Neuropsychological Scores in Atrophy Models Improves Diagnostic Classification of Alzheimer's Disease and Mild Cognitive Impairment |
| Q47285521 | Individual classification of mild cognitive impairment subtypes by support vector machine analysis of white matter DTI. |
| Q36106356 | Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease |
| Q37223790 | Inter-hemispheric functional dysconnectivity mediates the association of corpus callosum degeneration with memory impairment in AD and amnestic MCI. |
| Q38376310 | Is "Learning" episodic memory? Distinct cognitive and neuroanatomic correlates of immediate recall during learning trials in neurologically normal aging and neurodegenerative cohorts |
| Q36341967 | Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging |
| Q90285716 | Lesions of retrosplenial cortex spare immediate-early gene activity in related limbic regions in the rat |
| Q24735341 | Longitudinal Analysis of Image Time Series with Diffeomorphic Deformations: A Computational Framework Based on Stationary Velocity Fields |
| Q30587067 | Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease |
| Q37495065 | Longitudinal clinical score prediction in Alzheimer's disease with soft-split sparse regression based random forest |
| Q31153983 | Longitudinal imaging in dementia. |
| Q53279953 | Looking beyond the hippocampus: old and new neurological targets for understanding memory disorders. |
| Q36958569 | MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD. |
| Q24645655 | MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment |
| Q37028247 | MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer's disease |
| Q34215535 | Machine learning and radiology |
| Q31049661 | Magnetic resonance imaging of Alzheimer's disease |
| Q36257224 | Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease |
| Q37131880 | Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment |
| Q35486187 | Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. |
| Q30484077 | Mapping the progression of progranulin-associated frontotemporal lobar degeneration |
| Q51035762 | Medial Parietal Cortex Encodes Perceived Heading Direction in Humans |
| Q37107916 | Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease. |
| Q93265174 | Memory Performance and Quantitative Neuroimaging Software in Mild Cognitive Impairment: A Concurrent Validity Study |
| Q27687485 | Memory loss in Alzheimer's disease |
| Q51760400 | Missing the egocentric spatial reference: a blank on the map. |
| Q37223726 | Molecular nexopathies: a new paradigm of neurodegenerative disease |
| Q29614724 | Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory |
| Q37395662 | Multi-Atlas Segmentation with Joint Label Fusion. |
| Q30372750 | Musical tasks targeting preserved and impaired functions in two dementias |
| Q34126524 | Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI |
| Q47337446 | Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease |
| Q37640506 | Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer's disease |
| Q33581593 | Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study |
| Q53293735 | Neurodegeneration and the structure of time: clinical evidence for philosophical reasoning. |
| Q36017047 | Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial |
| Q30654332 | Neuroimaging of dementia in 2013: what radiologists need to know |
| Q38161007 | Neuroimaging studies in Alzheimer's disease. A review |
| Q49808096 | Neuroinflammation in Alzheimer's Disease: Pleiotropic Roles for Cytokines and Neuronal Pentraxins |
| Q37057978 | Neuropathological basis of magnetic resonance images in aging and dementia |
| Q36274037 | New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials |
| Q27687739 | Nitric Oxide and the Biological Cascades Underlying Increased Neurogenesis, Enhanced Learning Ability, and Academic Ability as an Effect of Increased Bouts of Physical Activity |
| Q36835545 | Non-invasive screening for early Alzheimer's disease diagnosis by a sensitively immunomagnetic biosensor. |
| Q35698877 | Non-monotonic reorganization of brain networks with Alzheimer's disease progression |
| Q24642943 | One-year brain atrophy evident in healthy aging |
| Q30484317 | Open access series of imaging studies: longitudinal MRI data in nondemented and demented older adults |
| Q39463015 | Optimal weights for multi-atlas label fusion. |
| Q41284835 | Optimization of brain perfusion image quality by cortical surface-based projection of arterial spin labeling maps in early-onset Alzheimer's disease patients |
| Q27022527 | Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research |
| Q52632555 | Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence. |
| Q36600561 | Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease. |
| Q34715043 | Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies |
| Q55069579 | Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study. |
| Q38108263 | Posterior cortical atrophy and Alzheimer's disease: a meta-analytic review of neuropsychological and brain morphometry studies. |
| Q48290805 | Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment |
| Q37335585 | Predicting the location of entorhinal cortex from MRI. |
| Q36298571 | Prediction and classification of Alzheimer disease based on quantification of MRI deformation |
| Q60960925 | Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI |
| Q39041947 | Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. |
| Q34652047 | Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment |
| Q93634262 | Proceedings of the Annual Meeting of the British Neuropsychiatry Association at the Institute of Child Health, London, 9–11 February 2005 |
| Q33547491 | Progression of atrophy in Alzheimer's disease and related disorders |
| Q34143302 | Progressive logopenic/phonological aphasia: erosion of the language network |
| Q30983010 | Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease |
| Q49074225 | Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study |
| Q37187740 | Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations |
| Q36300223 | Regionally selective atrophy after traumatic axonal injury |
| Q38739072 | Registration of longitudinal brain image sequences with implicit template and spatial-temporal heuristics |
| Q41843142 | Regression-Based Label Fusion for Multi-Atlas Segmentation |
| Q33987747 | Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study |
| Q45292937 | Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease |
| Q34039952 | Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data |
| Q44658155 | Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease) |
| Q53313597 | Revising the definition of Alzheimer's disease: a new lexicon. |
| Q22241579 | Role of imaging techniques in the diagnosis of dementia |
| Q34173192 | Role of structural MRI in Alzheimer's disease |
| Q48739961 | Saccade deficits in amnestic mild cognitive impairment resemble mild Alzheimer's disease |
| Q26859565 | Science to practice: translating automated brain MRI volumetry in Alzheimer's disease from research to routine diagnostic use in the work-up of dementia |
| Q33707724 | Selective disruption of the cerebral neocortex in Alzheimer's disease |
| Q91870987 | Sentence comprehension in patients with dementia of the Alzheimer's type |
| Q34002953 | Serial MRI and CSF biomarkers in normal aging, MCI, and AD |
| Q34081087 | Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans |
| Q59100479 | Significance of normalization on anatomical MRI measures in predicting Alzheimer's disease |
| Q57445135 | Sparse unbiased analysis of anatomical variance in longitudinal imaging |
| Q41532910 | Spatial Bias in Multi-Atlas Based Segmentation |
| Q57173226 | Spatial navigation deficits - overlooked cognitive marker for preclinical Alzheimer disease? |
| Q36049538 | Spatial navigation-a unique window into physiological and pathological aging |
| Q47878685 | Spatial patterns of progressive brain volume loss after moderate-severe traumatic brain injury |
| Q55229976 | Spatiotemporal Propagation of the Cortical Atrophy: Population and Individual Patterns. |
| Q85108599 | Standing on the shoulders of giants: improving medical image segmentation via bias correction |
| Q88613711 | Statistical Model of Dynamic Markers of the Alzheimer's Pathological Cascade |
| Q47799198 | Stress induced neural reorganization: A conceptual framework linking depression and Alzheimer's disease. |
| Q34981774 | Structural interactions within the default mode network identified by Bayesian network analysis in Alzheimer's disease |
| Q37755134 | Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease |
| Q33511721 | Structural neuroimaging in the detection and prognosis of pre-clinical and early AD. |
| Q34007166 | Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease |
| Q96687757 | TADPOLE Challenge: Accurate Alzheimer's disease prediction through crowdsourced forecasting of future data |
| Q36136071 | Task deactivation reductions and atrophy within parietal default mode regions are overlapping but only weakly correlated in mild cognitive impairment |
| Q37504560 | Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis |
| Q50968602 | Temporal order memory assessed during spatiotemporal navigation as a behavioral cognitive marker for differential Alzheimer's disease diagnosis. |
| Q37130132 | Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease. |
| Q26748827 | Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit |
| Q37133228 | Thalamic projections to the posteromedial cortex in the macaque |
| Q40218916 | The Impact of UNC5C Genetic Variations on Neuroimaging in Alzheimer's Disease |
| Q36496436 | The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease |
| Q28254943 | The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease |
| Q36073680 | The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease |
| Q34795067 | The association between cardiovascular risk factors and progressive hippocampus volume loss in persons with Alzheimer's disease |
| Q48106442 | The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study |
| Q38825197 | The clinical spectrum of sporadic and familial forms of frontotemporal dementia. |
| Q24609648 | The clinical use of structural MRI in Alzheimer disease |
| Q37090083 | The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals |
| Q34165340 | The diagnosis of young-onset dementia. |
| Q35643088 | The dynamics of cortical and hippocampal atrophy in Alzheimer disease |
| Q90450363 | The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease |
| Q33902744 | The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition |
| Q47905232 | The influence of strategic encoding on false memory in patients with mild cognitive impairment and Alzheimer's disease dementia |
| Q33958629 | The origin of projections from the posterior cingulate and retrosplenial cortices to the anterior, medial dorsal and laterodorsal thalamic nuclei of macaque monkeys |
| Q44524650 | The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. |
| Q40584100 | The relationship between habitual physical activity status and executive function in individuals with Alzheimer's disease: a longitudinal, cross-lagged panel analysis |
| Q21131070 | The relationship of topographical memory performance to regional neurodegeneration in Alzheimer's disease |
| Q31032781 | The role of biomarkers in clinical trials for Alzheimer disease |
| Q49242306 | The self-reference effect in dementia: Differential involvement of cortical midline structures in Alzheimer's disease and behavioural-variant frontotemporal dementia |
| Q48276147 | The topography of grey matter involvement in early and late onset Alzheimer's disease |
| Q38269851 | The use and misuse of short cognitive tests in the diagnosis of dementia |
| Q48819459 | The use of metacognitive strategies to decrease false memories in source monitoring in patients with mild cognitive impairment. |
| Q34134551 | The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to AD |
| Q35401374 | Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease |
| Q48426170 | Topographical short-term memory differentiates Alzheimer's disease from frontotemporal lobar degeneration |
| Q35471302 | Transient ischaemic attacks are associated with increased rates of global cerebral atrophy |
| Q37638379 | Ventriculomegaly associated with ependymal gliosis and declines in barrier integrity in the aging human and mouse brain. |
| Q36165544 | Verbal and non-verbal memory and hippocampal volumes in a memory clinic population |
| Q38379458 | Verbal learning in Alzheimer's disease: cumulative word knowledge gains across learning trials |
| Q35552599 | Visual assessment of posterior atrophy development of a MRI rating scale |
| Q36058788 | Visual distraction: an altered aiming spatial response in dementia |
| Q51903911 | Visuomotor integration is compromised in Alzheimer's disease patients reaching for remembered targets. |
| Q48457345 | Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations |
| Q33750964 | Voxel-based assessment of gray and white matter volumes in Alzheimer's disease |
| Q48447129 | Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations |
| Q28260803 | What does the retrosplenial cortex do? |
| Q37183109 | Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment |
| Q30783478 | Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging |
| Q80027960 | [At the boundary between normal aging and Alzheimer disease] |
| Q53383626 | [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging]. |